Browse by category

French researchers have developed a new drug delivery system that could cut the dosing schedule for type 2 diabetes and weight control...

Taking the weight loss medication semaglutide does not increase the risk of depressive symptoms, suicidal thoughts or suicidal behaviour...

Semaglutide reduced the rates of COVID-19-related adverse events, including death, in those who had overweight or obesity and established...

The anti-obesity medication semaglutide may help to prevent heart attacks and other major adverse cardiac events (MACE) among people...

Diabetes severity, as assessed by the individualised metabolic surgery (IMS), can help predict the weight loss outcomes achieved by...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Individuals with overweight or obesity treated with tirzepatide were significantly more likely to achieve clinically meaningful weight...

Patients prescribed semaglutide (as Ozempic or Wegovy) for diabetes or weight loss had a higher risk of having a potentially blinding eye...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

The World Health Organization (WHO) has issued a medical product alert on falsified semaglutides, the type of medicines that are used for...